查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869712

病毒携带者筛检市场规模、份额和趋势分析报告：按疾病、类型、技术、应用、地区和细分市场预测（2025-2033 年）

Carrier Screening Market Size, Share & Trends Analysis Report By Medical Conditions, By Type, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

载体筛检市场摘要

2024 年全球病毒携带者筛检市场规模估计为 15.3224 亿美元，预计到 2033 年将达到 40.4529 亿美元。

预计从 2025 年到 2033 年，该市场将以 11.95% 的复合年增长率成长。遗传疾病的日益普遍、基因检测技术的进步、人们意识的提高以及对个人化医疗的需求是推动市场成长的主要因素。

例如，根据世界卫生组织（世卫组织）的数据，大约每1,000人中就有10人患有罕见的单基因疾病，这意味着全球有7,000万至8,000万人患有此类疾病。光是在美国，镰状细胞疾病（SCD）就影响超过10万人，在非裔美国人的盛行率明显更高。

筛检技术的进步，特别是次世代定序（NGS）和生物资讯学的发展，显着提升了携带者筛检市场的准确性、速度和经济性。传统的基因筛检测试主要针对少数疾病，目标族群也较为单一，例如特定族群或高风险族群。相较之下，基于NGS的现代panel检测可在单次测试中筛检数百种基因突变，提供更广泛、更全面的评估。例如，2025年2月，瑞士罗氏公司推出了一种名为「扩增次世代定序」（SBX）的新技术。该技术在阐明癌症、免疫系统疾病和神经退化性疾病等复杂疾病方面发挥重要作用。 SBX技术利用高通量感测器模组和合成分子来确定目标分子的DNA序列。

此外，人们对遗传风险的日益关注以及全球范围内向个人化医疗的转变，正在推动携带者筛检产业的扩张。个人和夫妇在管理自身生殖健康方面变得更加积极主动，并且越来越多地寻求遗传咨询与筛检相结合。这反映出人们越来越认识到，携带者状态对家庭计画、怀孕结局以及后代的健康有着直接的影响。

携带者筛检的基础在于提高公众意识，透过早期检测计画改善健康状况。早期项目，例如在德系犹太社区开展的戴-萨克斯病筛检，展现了教育和检测在显着降低疾病盛行率方面的潜力。同样，在非裔美国人群体中开展的社区主导的镰状细胞病筛检镰状强调了积极参与的重要性，而后来政府主导揭示了实施不力以及资讯误导的风险。这些历史经验凸显了个人化医疗的更广泛趋势，即个人和社区越来越倾向于寻求遗传知识，以便做出明智的生育和医疗决策。

然而，市场面临的主要挑战之一是，传统的短读次世代定序技术难以分析基因组中的复杂区域，例如重复序列扩增、结构变异、甲基化特征和高度同源基因。为了因应这些挑战，包括HiFi技术在内的高精度长读长定定序等创新技术应运而生。例如，PacBio于2025年9月宣布推出其扩展的PureTarget产品组合，用于利用HiFi定序技术进行高通量带原者筛检。这些解决方案透过将多种检测方法整合到单一可扩展的测试中，简化了工作流程，从而能够对难以分析的基因进行精确分析。

目录

第一章 职业筛检市场：调查方法与范围

2. 职业筛检市场：执行摘要

  • 市场概述
  • 医疗状况
  • 类型简介
  • 技术概览
  • 最终用途简介
  • 竞争格局概览

第三章 病毒筛检市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 遗传性疾病盛行率不断上升
    • 基因检测技术的进步
    • 人们对个人化医疗的认识和需求日​​益增长
  • 市场限制因素分析
    • 有限的公共卫生检测
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 带因者筛检市场：疾病预测与趋势分析

  • 带因者筛检市场：疾病波动分析
  • 脊髓性肌肉萎缩症
  • 囊肿纤维化
  • 戴-萨克斯病
  • 高雪氏症
  • 镰状细胞性贫血症
  • 其他的

第五章 病毒携带者筛检市场：类型估算与趋势分析

  • 载体筛检市场：类型差异分析
  • 扩大携带者筛检
  • 针对性疾病携带者的筛检

第六章 病毒携带者筛检市场：技术预测与趋势分析

  • 病毒携带者筛检市场：波动分析
  • DNA序列分析
  • 聚合酵素链锁反应
  • 微阵列
  • 其他技术（MLPA、基因分型、酵素筛检）

第七章 病毒携带者筛检市场：终端使用者估算与趋势分析

  • 载体筛检市场：最终用途差异分析
  • 医院
  • 研究所
  • 医生办公室和诊所
  • 其他最终用户

第八章 职业筛检市场：区域业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品上市
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 主要企业市占率分析，2024 年
  • 公司热力图分析
  • 公司简介
    • Myriad Genetics, Inc.
    • BGI Genomics
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc
    • F. Hoffmann-La Roche Ltd
    • Laboratory Corporation of America Holdings（LabCorp）
    • Otogenetics Corporation
    • MedGenome
    • GeneTech（ATS Genetech Pvt Ltd）
    • CENTOGENE GmbH
Product Code: GVR-4-68040-016-9

Carrier Screening Market Summary

The global carrier screening market size was estimated at USD 1,532.24 million in 2024 and is projected to reach USD 4,045.29 million by 2033, growing at a CAGR of 11.95% from 2025 to 2033. The rising prevalence of genetic disorders, technological advancements in genetic testing, growing awareness, and demand for personalized medicine are major factors driving the market's growth.

For instance, according to the World Health Organization, around 10 in every 1,000 individuals are affected by rare single-gene disorders, translating to between 70 million and 80 million people worldwide living with such conditions. Sickle cell disease (SCD) alone impacts more than 100,000 people in the U.S., with a particularly high prevalence among people of African American origin.

The growing technological advancement in screening techniques, particularly in next-generation sequencing (NGS) and bioinformatics, has transformed the carrier screening market by improving accuracy, speed, and affordability. Traditional genetic screening tests typically focused on a limited set of conditions, targeting specific populations or high-risk groups. In contrast, modern NGS-based panels screen hundreds of genetic mutations in a single run, providing a much broader and more comprehensive assessment. For instance, in February 2025, F. Hoffmann-La Roche AG (Switzerland) introduced a new category of next-generation sequencing by expansion (SBX) technology, which is playing a vital role in decoding complex diseases like cancer, immune disorders and neurodegenerative conditions. This technology uses high throughput sensor module along with synthetic molecules in order to determine the DNA sequence of a target molecule.

Moreover, the expansion of the carrier screening industry is propelled by rising awareness of genetic risks and the global shift toward personalized medicine. Individuals and couples are becoming increasingly proactive in managing reproductive health, seeking genetic counseling along with screening. This reflects a growing understanding that carrier status has direct implications for family planning, pregnancy outcomes, and the health of future generations.

The foundation of carrier screening lies in raising awareness to improve health outcomes through early detection programs. Early programs such as Tay-Sachs disease screening in Ashkenazi Jewish communities demonstrated how education and testing could drastically reduce disease prevalence. Similarly, community-driven sickle cell screening efforts in African American populations underscored the importance of proactive engagement, though later government-led initiatives revealed the risks of poor implementation and misinformation. These historical lessons emphasize a broader trend toward personalized medicine, where individuals and communities increasingly seek genetic insights to make informed reproductive and healthcare decisions.

However, one of the major challenges in the market emerges as traditional short-read NGS struggles with complex regions of the genome, including repeat expansions, structural variants, methylation signatures, and high-homology genes. To address these gaps, innovations such as highly accurate long-read sequencing, including HiFi technologies, are emerging. For instance, in September 2025, PacBio launched its expanded PureTarget portfolio for high-throughput carrier screening, powered by HiFi sequencing technology. The solutions streamline workflows by consolidating multiple assays into a single scalable test, enabling accurate analysis of challenging genes.

Global Carrier Screening Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global carrier screening market report based on medical conditions, type, technology, end-use, and region:

  • Medical Conditions Outlook (Revenue, USD Million, 2021 - 2033)
  • Spinal Muscular Atrophy
  • Cystic Fibrosis
  • Tay-Sachs
  • Gaucher Disease
  • Sickle Cell Disease
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Expanded Carrier Screening
  • Targeted Disease Carrier Screening
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Other Technologies (MLPA, Genotyping, Enzyme Screening)
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Laboratories
  • Physician Offices & Clinics
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Carrier Screening Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Medical Conditions
      • 1.1.1.2. Type Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Carrier Screening Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Medical Conditions
  • 2.3. Type Snapshot
  • 2.4. Technology Snapshot
  • 2.5. End use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Carrier Screening Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising prevalence of genetic disorders
    • 3.4.2. Technological advancements in genetic testing
    • 3.4.3. Growing awareness and demand for personalized medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Limited implementation of public health screening
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Carrier Screening Market: Medical Conditions Estimates & Trend Analysis

  • 4.1. Carrier Screening Market: Medical Conditions Movement Analysis
  • 4.2. Spinal Muscular Atrophy
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Cystic Fibrosis
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Tay-Sachs
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Gaucher Disease
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Sickle Cell Disease
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Carrier Screening Market: Type Estimates & Trend Analysis

  • 5.1. Carrier Screening Market: Type Movement Analysis
  • 5.2. Expanded Carrier Screening
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Targeted Disease Carrier Screening
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Carrier Screening Market: Technology Estimates & Trend Analysis

  • 6.1. Carrier Screening Market: End Use Movement Analysis
  • 6.2. DNA Sequencing
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Polymerase Chain Reaction
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Microarrays
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Other Technologies (MLPA, Genotyping, Enzyme Screening)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Carrier Screening Market: End Use Estimates & Trend Analysis

  • 7.1. Carrier Screening Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Physician Offices & Clinics
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Other End Users
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Carrier Screening Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Carrier Screening Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. Middle East & Africa
    • 8.6.1. Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. NEW PRODUCT LAUNCH
    • 9.2.2. PARTNERSHIPS
    • 9.2.3. ACQUISITION
    • 9.2.4. COLLABORATION
    • 9.2.5. FUNDING
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. Myriad Genetics, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. BGI Genomics
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Illumina, Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Thermo Fisher Scientific, Inc
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Laboratory Corporation of America Holdings (LabCorp)
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Otogenetics Corporation
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. MedGenome
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. GeneTech (ATS Genetech Pvt Ltd)
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. CENTOGENE GmbH
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Carrier Screening Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 5 Global Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 6 Global Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 10 North America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 11 North America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 14 U.S. Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 18 Canada Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 19 Canada Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 22 Mexico Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 23 Mexico Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 27 Europe Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Europe Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 31 UK Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 32 UK Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 UK Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 35 Germany Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 36 Germany Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 39 France Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 France Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 France Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 43 Italy Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 44 Italy Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 47 Spain Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 48 Spain Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 51 Sweden Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 52 Sweden Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 53 Sweden Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 55 Norway Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 Norway Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 59 Denmark Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 60 Denmark Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 Denmark Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 68 Japan Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 69 Japan Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Japan Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 72 China Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 73 China Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 China Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 76 India Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 77 India Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 78 India Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 80 Australia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 81 Australia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 82 Australia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 84 Thailand Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 Thailand Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 88 South Korea Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 89 South Korea Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 90 South Korea Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 93 Latin America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Latin America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 97 Brazil Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 98 Brazil Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 101 Argentina Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 102 Argentina Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MIDDLE EAST & AFRICA Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 MIDDLE EAST & AFRICA Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 106 MIDDLE EAST & AFRICA Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 107 MIDDLE EAST & AFRICA Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 110 South Africa Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 111 South Africa Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 118 UAE Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 119 UAE Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Carrier Screening Market, By End Use, 32021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global carrier screening market- Key market driver analysis
  • Fig. 7 Global carrier screening market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global carrier screening market - Porter's analysis
  • Fig. 10 Global carrier screening market - PESTEL analysis
  • Fig. 11 Global carrier screening market Medical Conditions outlook key takeaways
  • Fig. 12 Global carrier screening market: Medical Conditions movement analysis
  • Fig. 13 Spinal muscular Atrophy market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Cystic fibrosis market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Tay-Sachs market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Gaucher disease market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Sickle cell disease market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Global carrier screening market technology outlook key takeaways
  • Fig. 20 Global carrier screening market: technology movement analysis
  • Fig. 21 Expanded carrier screening market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Targeted disease carrier screening market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Global carrier screening market technology outlook key takeaways
  • Fig. 24 Global carrier screening market technology movement analysis
  • Fig. 25 DNA sequencing market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Polymerase chain reaction market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Microarrays market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Other technologies (MLPA, genotyping, enzyme screening) market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Global carrier screening market end use outlook key takeaways
  • Fig. 30 Global carrier screening market end use movement analysis
  • Fig. 31 Hospitals market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Physician offices & clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Other end users market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Global Carrier Screening Market: Regional movement analysis
  • Fig. 37 North America Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 39 Canada Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 40 Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 41 Europe Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 42 UK Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 44 France Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 46 Italy Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 47 Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 49 Norway Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 50 Asia Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 51 Japan Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 52 China Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 53 India Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 55 Australia Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 60 Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 61 South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 62 Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 63 UAE Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 65 Strategy framework